Apr.—Beckman Coulter will help fund the Research in Immune Tolerance in Transplantation (RITT) program, an initiative committed to studying immune and transplant patients by identifying and preventing potential rejection problems. It was jointly funded with $10mm by Toronto General Hospital (TGH), the Canadian government, and the province of Ontario.
The collaboration has established the RITT Biodevelopment Laboratory at TGH to conduct studies supporting the RITT initiative, part of the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?